Cargando…

Novel and shared neoantigen for glioma T cell therapy derived from histone 3 variant H3.3 K27M mutation

Detalles Bibliográficos
Autores principales: Hou, Yafei, Kohanbash, Gary, Okada, Kaori, Shrivastav, Shruti, Smith-Cohn, Matthew, Nicolaides, Theodore, Mueller, Sabine, Carcaboso, Angel, Pollack, Ian, Okada, Hideho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652531/
http://dx.doi.org/10.1186/2051-1426-3-S2-P445
_version_ 1782401774580137984
author Hou, Yafei
Kohanbash, Gary
Okada, Kaori
Shrivastav, Shruti
Smith-Cohn, Matthew
Nicolaides, Theodore
Mueller, Sabine
Carcaboso, Angel
Pollack, Ian
Okada, Hideho
author_facet Hou, Yafei
Kohanbash, Gary
Okada, Kaori
Shrivastav, Shruti
Smith-Cohn, Matthew
Nicolaides, Theodore
Mueller, Sabine
Carcaboso, Angel
Pollack, Ian
Okada, Hideho
author_sort Hou, Yafei
collection PubMed
description
format Online
Article
Text
id pubmed-4652531
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46525312015-11-25 Novel and shared neoantigen for glioma T cell therapy derived from histone 3 variant H3.3 K27M mutation Hou, Yafei Kohanbash, Gary Okada, Kaori Shrivastav, Shruti Smith-Cohn, Matthew Nicolaides, Theodore Mueller, Sabine Carcaboso, Angel Pollack, Ian Okada, Hideho J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4652531/ http://dx.doi.org/10.1186/2051-1426-3-S2-P445 Text en Copyright © 2015 Hou et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Hou, Yafei
Kohanbash, Gary
Okada, Kaori
Shrivastav, Shruti
Smith-Cohn, Matthew
Nicolaides, Theodore
Mueller, Sabine
Carcaboso, Angel
Pollack, Ian
Okada, Hideho
Novel and shared neoantigen for glioma T cell therapy derived from histone 3 variant H3.3 K27M mutation
title Novel and shared neoantigen for glioma T cell therapy derived from histone 3 variant H3.3 K27M mutation
title_full Novel and shared neoantigen for glioma T cell therapy derived from histone 3 variant H3.3 K27M mutation
title_fullStr Novel and shared neoantigen for glioma T cell therapy derived from histone 3 variant H3.3 K27M mutation
title_full_unstemmed Novel and shared neoantigen for glioma T cell therapy derived from histone 3 variant H3.3 K27M mutation
title_short Novel and shared neoantigen for glioma T cell therapy derived from histone 3 variant H3.3 K27M mutation
title_sort novel and shared neoantigen for glioma t cell therapy derived from histone 3 variant h3.3 k27m mutation
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652531/
http://dx.doi.org/10.1186/2051-1426-3-S2-P445
work_keys_str_mv AT houyafei novelandsharedneoantigenforgliomatcelltherapyderivedfromhistone3varianth33k27mmutation
AT kohanbashgary novelandsharedneoantigenforgliomatcelltherapyderivedfromhistone3varianth33k27mmutation
AT okadakaori novelandsharedneoantigenforgliomatcelltherapyderivedfromhistone3varianth33k27mmutation
AT shrivastavshruti novelandsharedneoantigenforgliomatcelltherapyderivedfromhistone3varianth33k27mmutation
AT smithcohnmatthew novelandsharedneoantigenforgliomatcelltherapyderivedfromhistone3varianth33k27mmutation
AT nicolaidestheodore novelandsharedneoantigenforgliomatcelltherapyderivedfromhistone3varianth33k27mmutation
AT muellersabine novelandsharedneoantigenforgliomatcelltherapyderivedfromhistone3varianth33k27mmutation
AT carcabosoangel novelandsharedneoantigenforgliomatcelltherapyderivedfromhistone3varianth33k27mmutation
AT pollackian novelandsharedneoantigenforgliomatcelltherapyderivedfromhistone3varianth33k27mmutation
AT okadahideho novelandsharedneoantigenforgliomatcelltherapyderivedfromhistone3varianth33k27mmutation